Advertisement
Advances in Pediatrics

Pediatric Chronic Kidney Disease

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Pediatrics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Goldstein S.
        • Gerson A.
        • Goldman C.
        • et al.
        Quality of life for children with chronic kidney disease.
        Semin Nephrol. 2006; 18: 114-117
        • Gerson A.
        • Wentz A.
        • Abraham A.
        • et al.
        Health-related quality of life of children with mild to moderate chronic kidney disease.
        Pediatrics. 2010; 125: e349-e357
        • Tjaden L.
        • Tong A.
        • Henning P.
        • et al.
        Children's experiences of dialysis: a systematic review of qualitative studies.
        Arch Dis Child. 2012; 97: 395
        • Baum M.
        Overview of chronic kidney disease in children.
        Curr Opin Pediatr. 2010; 22: 158-160
        • Wong C.
        • Moxey-Mims M.
        • Jerry-Fluker J.
        • et al.
        CKiD (CKD in children) prospective cohort study: a review of current findings.
        Am J Kidney Dis. 2012; 60: 1002-1011
        • Harambat J.
        • et al.
        Epidemiology of chronic kidney disease in children.
        Pediatr Nephrol. 2012; 27: 363-373
        • Warady B.A.
        • Chadha V.
        Chronic kidney disease in children: the global perspective.
        Pediatr Nephrol. 2007; 22: 1999-2009
        • Ding W.
        • Cheung W.
        • Mak R.
        Impact of obesity on kidney function and blood pressure in children.
        World J Nephrol. 2015; 4: 223-229
        • Staples A.
        • Wong C.
        Risk factors for progression of chronic kidney disease.
        Curr Opin Pediatr. 2010; 22: 161-169
        • Fuhrman D.
        • Schneider M.
        • Dell K.
        • et al.
        Albuminuria, Proteinuria, and renal disease progression in children with CKD.
        Clin J Am Soc Nephrol. 2017; 12: 912-920
        • Wühl E.
        • Schaefer F.
        Therapeutic strategies to slow chronic kidney disease progression.
        Pediatr Nephrol. 2008; 23: 705
        • Vikse B.
        • Irgens L.
        • Leivestad T.
        • et al.
        Low birth weight increases risk for end-stage renal disease.
        J Am Soc Nephrol. 2008; 19: 151-157
        • Carmody J.
        • Charlton J.
        Short-term gestation, long-term risk: prematurity and chronic kidney disease.
        Pediatrics. 2013; 131: 1168-1179
        • Moffett B.
        • Goldstein S.
        Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children.
        Clin J Am Soc Nephrol. 2011; 6: 856-863
        • Dionne J.
        Evidence-based guidelines for the management of hypertension in children with chronic kidney disease.
        Pediatr Nephrol. 2015; 30: 1919-1927
        • Webb N.
        • Shahinfar S.
        • Wells T.
        • et al.
        Losartan and enalapril are comparable in reducing proteinuria in children.
        Kidney Int. 2012; 82: 819-826
        • Abraham A.
        • Betoko A.
        • Fadrowski J.
        • et al.
        Renin-angiotensin II-aldosterone system blockers and time to renal replacement therapy in children with CKD.
        Pediatr Nephrol. 2017; 32: 643-649
        • Ng D.
        • Levey A.
        • Shlipak M.
        • et al.
        Validation of a simple equation for glomerular filtration rate measurement based on plasma iohexol disappearance.
        Clin Kidney J. 2019; 13: 397-401
        • Schwartz G.
        • Schneider M.
        • Maier P.
        • et al.
        Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C.
        Kidney Int. 2012; 82: 445-453
        • Ferguson T.
        • Komenda P.
        • Tangri N.
        Cystatin C as a biomarker for estimating glomerular filtration rate.
        Curr Opin Nephrol Hypertens. 2015; 24: 295-300
        • Schwartz G.
        • Munoz A.
        • Schneider M.
        • et al.
        New equations to estimate GFR in children with CKD.
        J Am Soc Nephrol. 2009; 20: 629-637
        • Schwartz G.
        • Work D.
        Measurement and estimation of GFR in children and adolescents.
        J Am Soc Nephrol. 2009; 4: 643-1832
        • Wong H.
        • Mylrea K.
        • Feber J.
        • et al.
        Prevalence of complications in children with chronic kidney disease according to KDOQI.
        Kidney Int. 2006; 70: 585-590
        • Levin A.
        • Stevens P.
        • Bilous R.
        • et al.
        Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease.
        Kidney Int S. 2013; 3: 1-150
        • Hogg R.
        • Furth S.
        • Lemley K.
        • et al.
        National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification.
        Pediatrics. 2003; 111: 1416-1421
        • Becherucci F.
        • Roperto R.
        • Materassi M.
        • et al.
        Chronic kidney disease in children.
        Clin Kidney J. 2016; 9: 583-591
        • Furth S.L.
        • Pierce C.
        • Wui W.
        • et al.
        Estimating time to ESRD in children with CKD.
        Am J Kidney Dis. 2018; 71: 783-792
        • Michal L.
        • Melamed K.
        • Raphael L.
        Metabolic acidosis in CKD: A review of recent findings.
        Kidney Med. 2021; 3: 267-277
        • Chen W.
        • Abramowitz M.
        Metabolic acidosis and the progression of chronic kidney disease.
        BMC Nephrol. 2014; 15
        • Harambat J.
        • Kunzmann K.
        • Azukaitis K.
        • et al.
        Metabolic acidosis is common and associates with disease progression in children with chronic kidney disease.
        Kidney Int. 2017; 92: 1507-1514
        • Bertholet-Thomas A.
        • Guittet C.
        • Manso-Silvan M.
        • et al.
        Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments.
        Pediatr Nephrol. 2021; 36: 83-91
        • Wesseling-Perry K.
        Bone disease in pediatric chronic kidney disease.
        Pediatr Nephrol. 2013; 28: 569-576
        • National Kidney Foundation. K/DOQI
        Clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease.
        Am J Kidney Dis. 2005; 46: S12
        • Martin K.
        • González E.
        Metabolic bone disease in chronic kidney disease.
        J Am Soc Nephrol. 2007; 18: 875-885
        • D’Alessandro C.
        • Piccoli G.
        • Cupisti A.
        The “phosphorus pyramid”: a visual tool for dietary phosphate management in dialysis and CKD patients.
        BMC Nephrol. 2015; 16
        • McAlister L.
        • Pugh P.
        • Greenbaum L.
        • et al.
        The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis-clinical practice recommendation from the pediatric renal nutrition taskforce.
        Pediatr Nephrol. 2020; 35: 501-518
        • Hahn D.
        • Hodson E.
        • Craig J.
        Interventions for metabolic bone disease in children with chronic kidney disease.
        Cochrane Database Syst Rev. 2015; 11
        • Klaus G.
        • Watson A.
        • Edefonti A.
        • et al.
        Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines.
        Pediatr Nephrol. 2006; 21: 151-159
        • Moe S.
        • Drüeke T.
        Management of secondary hyperparathyroidism: the importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus product.
        Am J Nephrol. 2003; 23: 369-379
        • Warady B.
        • Ng E.
        • Bloss L.
        • et al.
        Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis.
        Pediatr Nephrol. 2020; 35: 1679-1697
        • Greenbaum L.A.
        Anemia in children with chronic kidney disease.
        Adv Chronic Kidney Dis. 2005; 12: 385-396
        • Atkinson M.A.
        • White C.T.
        Hepcidin in anemia of chronic kidney disease: review for the pediatric nephrologist.
        Pediatr Nephrol. 2012; 27: 33-40
        • Schaefer F.
        • Hoppe B.
        • Jungraithmayr T.
        • et al.
        Safety and usage of darbepoetin alfa in children with chronic kidney disease: prospective registry study.
        Pediatr Nephrol. 2016; 31: 443-453
        • K/DOQI; National Kidney Foundation
        Clinical practice recommendations for anemia in chronic kidney disease in children.
        Am J Kidney Dis. 2006; 47: S86-S108
        • Gerson A.
        • Hwang W.
        • Fiorenza J.
        • et al.
        Anemia and health-related quality of life in adolescents with chronic kidney disease.
        Am J Kidney Dis. 2004; 44: 1017-1023
        • Mitsnefes M.
        Cardiovascular complications of pediatric chronic kidney disease.
        Pediatr Nephrol. 2008; 23: 27-39
        • Rinat C.
        • Becker-Cohen R.
        • Nir A.
        • et al.
        A comprehensive study of cardiovascular risk factors, cardiac function and vascular disease in children with chronic renal failure.
        Nephrol Dial Transpl. 2010; 25: 785-793
        • Sethna C.
        • Merchant K.
        • Reyes A.
        Cardiovascular disease risk in children with kidney disease.
        Semin Nephrol. 2018; 38: 298-313
        • Brady T.
        • Schnieder M.
        • Flynn J.
        • et al.
        Carotid intima-media thickness in children with CKD: results from the CKiD study.
        Clin J Am Soc Nephrol. 2012; 7: 1930-1937
        • Brady T.
        • Roem J.
        • Cox C.
        • et al.
        Adiposity, sex, and cardiovascular disease risk in children with CKD: a longitudinal study of youth enrolled in the Chronic Kidney Disease in Children (CKiD) study.
        Am J Kidney Dis. 2020; 76: 166-173
        • Le Palma K.
        • Rampolla Pavlick E.
        • Copelovitch L.
        Pretreatment of enteral nutrition with sodium polystyrene sulfonate: effective, but beware the high prevalence of electrolyte derangements in clinical practice.
        Clin Kidney J. 2018; 11: 166-171
        • Sgambat K.
        • Amatya K.
        • Moudgil A.
        Nutritional challenges across the spectrum of chronic kidney disease.
        Asian J Pediatr Nephrol. 2019; 2: 2-15
        • Ledermann S.
        • Spitz L.
        • Moloney J.
        • et al.
        Gastrostomy feeding in infants and children on peritoneal dialysis.
        Pediatr Nephrol. 2002; 17: 246-250
        • Al-Uzri A.
        • Matheson M.
        • Gipson D.
        • et al.
        The impact of short stature on health-related quality of life in children with chronic kidney disease.
        J Pediatr. 2013; 163: 736-741
        • Brown D.
        • Dauber A.
        Growth hormone and insulin-like growth factor dysregulation in pediatric chronic kidney disease.
        Horm Res Paediatr. 2021; 94: 105-114
        • Stonebrook E.
        • Mahan J.
        Treatment of growth retardation in a child with CKD.
        Clin J Am Soc Nephrol. 2019; 14: 1658-1660
        • Mahan J.
        • Warady B.
        • et al.
        Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement.
        Pediatr Nephrol. 2006; 21: 917-930
        • Mahesh S.
        • Kaskel F.
        Growth hormone axis in chronic kidney disease.
        Pediatr Nephrol. 2008; 23: 41-48
        • K/DOQI, National Kidney Foundation
        Clinical practice guidelines for nutrition in chronic renal failure.
        Am J Kidney Dis. 2000; 35: S1
        • Drube J.
        • Wan M.
        • Bonthuis M.
        • et al.
        Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease.
        Nat Rev Nephrol. 2019; 15: 577-589
        • Van der Heijden B.
        • Van Dijk P.
        • Verrier-Jones K.
        • et al.
        Renal replacement therapy in children: data from 12 registries in Europe.
        Pediatr Nephrol. 2004; 19: 213-221
        • Chesnaye N.C.
        • Schaefer F.
        • Bonthuis M.
        • et al.
        Mortality risk disparities in children receiving chronic renal replacement therapy for the treatment of end-stage renal disease across Europe: an ESPN-ERA/EDTA registry analysis.
        Lancet. 2017; 389: 2128
        • Esposito S.
        • Mastrolia M.
        • Prada E.
        • et al.
        Vaccine administration in children with chronic kidney disease.
        Vaccine. 2014; 32: 6601-6606
        • Neu A.
        Immunizations in children with chronic kidney disease.
        Pediatr Nephrol. 2012; 27: 1257-1263
        • Groothoff J.
        • Grootenhuis M.
        • Offringa M.
        • et al.
        Social consequences in adult life of end-stage renal disease in childhood.
        J Pediatr. 2005; 146: 512
        • Tjaden L.
        • Maurice-Stam H.
        • Grootenhuis M.
        • et al.
        Impact of renal replacement therapy in childhood on long-term socioprofessional outcomes: a 30-year follow-up study.
        J Pediatr. 2016; 171: 189